The Performance of Patient Support Program in Early Stage Breast Cancer - ARI NIS
Study identifier:NIS-OCN-ARI-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Prospective, Multicentre, Controlled, Observational Study to Evaluate the Performance of Patient Support Programme (PSP) in Improving Patient Adherence with Adjuvant Aromatase Inhibitors (AI) medication for Postmenopausal, Early Stage Breast Cancer
Medical condition
Breast Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
524
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Sept 2008
Primary Completion Date: -
Study Completion Date: 01 Oct 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Standard Treatment plus PSP | - |
| 2 Standard Treatment | - |
Contacts
Investigators
Principal Investigator
Karen Atkin
AstraZeneca
